Fresenius Group Overview

The Health Care Group
Stories
Archive „Stories“
Investors
Contact

Fresenius SE & Co. KGaA

Investor Relations & Sustainability

+49 (0) 6172 608-2485
ir-fre@fresenius.com
Media
- News
- Social Media
- Calendar
- Contacts
- Media Center
Contact

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Careers
Menu
Filter results
- Chapter
- Format
  - Website (0)
  - PDF (0)
Share
- Facebook
- Twitter
- LinkedIn
- Xing
- E-Mail
Services
- Deutsch
- Print
- Contact
- RSS

Media

Corporate Communications

Here you can find a variety of information:

Our Corporate Communications team can be reached at pr-fre@fresenius.com.

“A pharmacy today? We need to expand it or add something new to it.” (Dr. Eduard Fresenius, Founder, 1912)

NEXT EVENT

February 23, 2021 | Bad Homburg, Germany

Conference Call Full Year Results 2020, Fresenius

Live Webcast

Import (ICS)

NEXT EVENT
NEXT EVENT

February 23, 2021 - 11:00 AM | Bad Homburg, Germany

Press Conference Full Year Results 2020, Fresenius and Fresenius Medical Care

Live Webcast

Import (ICS)

NEXT EVENT
LATEST

February 20, 2020 - 10:00 AM | Bad Homburg, Germany

Press Conference Full Year Results 2019, Fresenius and Fresenius Medical Care

Webcast replay

Webcast replay Import (ICS) Press Release Fresenius (PDF) Press Release Fresenius Medical Care (PDF) Presentation Fresenius (PDF) Presentation Fresenius Medical Care (PDF)

LATEST

News

Fresenius Medical Care’s Frenova enrolls patients in initiative to build world’s largest genomic registry targeting kidney disease

Fresenius Medical Care announced today that the company’s Frenova division has enrolled the first participants in its new initiative to develop the largest renal-focused genomic registry in the world.
January 11, 2021Fresenius Medical Care
Fresenius Medical Care expands critical care offering with ExThera Medical’s Seraph 100 adsorber

Fresenius Medical Care will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now.
January 07, 2021Fresenius Medical Care
Fresenius Helios acquires fertility services provider Eugin Group

Fresenius Helios acquires Eugin Group, one of the leading international fertility groups. Eugin Group’s network comprises 31 clinics and additional 34 sites across 9 countries on 3 continents.
December 21, 2020Fresenius Helios
Brief News
Fresenius Medical Care improves in climate and water ranking

Fresenius Medical Care has improved in this year's ranking of the non-profit organization CDP (formerly "Carbon Disclosure Project"). In both the 'Climate' and 'Water' areas, Fresenius Medical Care improved to category B and B-, respectively. With the ranking in the second highest category B, Fresenius Medical Care is one of the leading companies in the health care sector. Companies in categories A and B are characterized by transparency, coordinated climate and water protection measures, and the implementation of corresponding best-practice approaches. CDP is one of the most renowned climate and environmental rankings in the capital market. More than 515 investors use the annual results to evaluate climate protection activities and climate-related risks and opportunities of the companies assessed.

December 14, 2020Fresenius Medical Care

Brief News
Fresenius improves in climate ranking

Fresenius has once again improved in this year's CDP ranking (formerly "Carbon Disclosure Project"). With a ranking in the second highest category B, Fresenius is one of the leading companies in the health care sector, both in Europe and globally. Companies in categories A and B are characterized by transparency, coordinated climate protection measures and the implementation of corresponding best-practice approaches. CDP is one of the most renowned climate and environmental rankings in the capital market. More than 515 investors use the annual results to evaluate climate protection activities and climate-related risks and opportunities of the companies assessed.

December 11, 2020Fresenius
Fresenius Medical Care employee in Schweinfurt is Germany’s best apprentice in her specialty as electronics technician

December 07, 2020Fresenius Medical Care

Brief News
Fresenius Medical Care included for 11th time in Dow Jones Sustainability Index

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, has been recognized for the 11th time as a sustainability leader with inclusion in the Dow Jones Sustainability Index (DJSI Europe). The DJSI Europe index represents the top 20 percent of the largest 600 European companies in the S&P Global BMI, based on the international investment company S&P Global’s analysis of their economic, environmental and social performance.

November 16, 2020Fresenius Medical Care
Brief News
Fresenius Helios reporting figures on intensive care occupancy

Fresenius Helios has started publishing daily figures on the occupancy rate for intensive care beds in its 86 German hospitals. The website of each hospital will report the number of COVID-19 patients in the hospital’s regular and intensive care wards. It will also publish figures from the Robert Koch Institute, Germany’s national health agency, on the number of new infections in the surrounding region. Helios’ goal is to increase transparency and facilitate a data-based assessment of the pandemic at the local level. Helios Germany currently has a total of 1,300 intensive care beds across the country and could add an additional 1,000 on short notice, in the event of a sharp increase in COVID-19 hospitalizations.

November 02, 2020Fresenius Helios

Fresenius continues to demonstrate resilience amid the COVID-19 pandemic

October 29, 2020Fresenius
Fresenius Medical Care continues solid revenue and strong earnings growth in the third quarter

October 29, 2020Fresenius Medical Care

Brief News
Fresenius Medical Care gets FDA approval for Biofine® PD solution bags

Fresenius Medical Care North America announced today that the U.S. Food and Drug Administration (FDA) has approved DELFLEX® peritoneal dialysis solutions in Biofine®, an innovative bag material. The milestone marks another important step in the company’s commitment to grow home dialysis through new and improved products. Biofine material generates less waste and is PVC-free, to the benefit of the environment. The new Biofine peritoneal dialysis solutions bag has a user-friendly design for easy storage and use, and will be produced on a new manufacturing line in the company’s Knoxville, Tennessee plant. It is expected to be made available first to a limited number of U.S. patients this fall.

October 20, 2020Fresenius Medical Care
Fresenius announces changes to Supervisory Board

October 13, 2020Fresenius

Brief News
Fresenius Helios expands reporting on quality standards

As part of its reporting on quality standards, Fresenius Helios is publishing data on the length of patient stays, patient security and antibiotic use in the company’s German hospitals for the first time. Data from every Helios hospital is compiled in a total of 46 quality categories, including the frequency of surgical interventions and their results, and then published annually. The comparing of different hospitals’ statistics through the Quality Medicine Initiative yields specific, concrete improvements that can be implemented in day-to-day hospital operations. The initiative, which was jointly founded by Fresenius Helios, now includes more than 400 hospitals in Germany and Switzerland.

October 09, 2020Fresenius Helios
Brief News
Fresenius Kabi launches its first RFID smart-labeled product in the U.S.

Diprivan® (Propofol) injection, an anesthetic, is the company’s first smart-labeled product with radio frequency identification (RFID) technology and the 20 mL vial is now available in this enhanced presentation in the U.S. The smart label enables hospitals to automatically identify, locate and manage their inventory. Fresenius Kabi expects to introduce numerous other products with RFID technology in the coming year.

October 08, 2020Fresenius Kabi

Fresenius Medical Care presents new strategy and announces new medium-term targets through 2025 at Capital Markets Day

October 08, 2020Fresenius Medical Care
Brief News
Fresenius Medical Care partners with Applied Health Signals company Livongo in the U.S.

Fresenius Medical Care North America announced a partnership with Livongo, the leading Applied Health Signals company in the U.S. This will enable the company to better deliver targeted, real-time care coordination services to patients with late-stage chronic kidney disease (CKD) under value based care agreements with insurance providers and the federal government, as well as manage their comorbidities such as diabetes and hypertension. By deploying innovative technologies and services, the partnership allows patients to receive personalized interventions including remote monitoring, biometrics, education, nutrition, weight management, and emotional support, with the goal to improve outcomes, slow progression of CKD, and reduce the overall cost of care. With earlier intervention, the company also seeks to increase optimal dialysis starts, as well as offer earlier evaluation of transplantation and home dialysis options.

October 08, 2020Fresenius Medical Care

Brief News
Fresenius Helios enters healthcare agreement with hotel operator in Spain

Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, has signed an agreement with Vincci Hotels to offer health care to guests in all accommodations in Spain. The service includes 24/7 medical assistance, either by video call, in person or by a doctor’s visit in the hotel, if necessary. This service is offered in several languages to meet the demands from international guests.

October 07, 2020Fresenius Helios
Brief News
Fresenius Medical Care expands collaboration with U.S. insurer Humana

Fresenius Medical Care North America and the health insurer Humana are broadening their collaboration. The goal is improved, better coordinated and more holistic care for eligible members, for example through expanded access to CKD care coordination services and transitional care units. In addition, the existing clinical network contract, which provides eligible members with access to dialysis at more than 2,600 Fresenius Kidney Care clinics, is being implemented as a value-based payment model. This means that reimbursement will be based on meeting agreed quality improvement and patient outcome goals.

October 06, 2020Fresenius Medical Care

The Power of Ideas and the people behind them: Fresenius Medical Care publishes 2020 Global Annual Medical Report

September 24, 2020Fresenius Medical Care
Fresenius successfully places bonds with a volume of one billion euros

September 21, 2020Fresenius

Disclaimer All news

Order Service News

Would you like to be included on our distribution list for media information? We would be happy to provide you with our latest press releases and brief news by e-mail. This service is free of charge and may be cancelled at any time.

Business & Finance

Medicine & Research

Brief News

German English

First name * Please enter your first name.

Last name * Please enter your lastname.

E-Mail Adress * Please enter your email-address.

Contact

Do you have other questions or need any more information?

Your contact:

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com

Follow us

The Health Care Group

Contact us

Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com

Contacts

Visit us